Quarter Period Statement Of Income

Astellas Pharma Inc. - Filing #7723677

Concept 2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
Quarter period statement of income
Statement of income
Net sales
613,657,000,000 JPY
629,915,000,000 JPY
Cost of sales
205,735,000,000 JPY
248,208,000,000 JPY
Gross profit (loss)
407,922,000,000 JPY
381,708,000,000 JPY
Selling, general and administrative expenses
421,413,000,000 JPY
366,108,000,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
-13,490,000,000 JPY
15,600,000,000 JPY
Non-operating income
Non-operating income
303,270,000,000 JPY
121,224,000,000 JPY
Non-operating expenses
Interest expenses
2,473,000,000 JPY
1,311,000,000 JPY
Non-operating expenses
4,089,000,000 JPY
2,649,000,000 JPY
Ordinary profit (loss)
285,690,000,000 JPY
134,174,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
12,000,000 JPY
23,000,000 JPY
Extraordinary income
8,476,000,000 JPY
18,141,000,000 JPY
Extraordinary losses
Impairment losses
JPY
2,130,000,000 JPY
Extraordinary losses
2,594,000,000 JPY
5,438,000,000 JPY
Profit (loss) before income taxes
291,573,000,000 JPY
146,877,000,000 JPY
Income taxes - current
16,035,000,000 JPY
6,426,000,000 JPY
Income taxes - deferred
-21,281,000,000 JPY
2,633,000,000 JPY
Income taxes
-5,246,000,000 JPY
9,059,000,000 JPY
Profit (loss)
296,818,000,000 JPY
296,818,000,000 JPY
296,818,000,000 JPY
296,818,000,000 JPY
137,818,000,000 JPY
137,818,000,000 JPY
137,818,000,000 JPY
137,818,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.